ArticleScientific reports2025
Prevalence and molecular characterization of multidrug resistant Campylobacter isolated from animals and humans as a one health approach.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Microbiota-derived indole limitsScience advances · 2026Article
- Article
- Raw Milk as a Source ofPathogens (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Campylobacteriosis is a significant zoonosis with major public health implications. This study aimed to investigate the prevalence, molecular characteristics, and antimicrobial resistance of Campylobacter spp. in animal (rectal swabs and milk), environmental (fecal, water, and wall swabs), and human samples (stool and hand swabs) in New Valley Governorate, Egypt. Among 573 samples analyzed, Campylobacter spp. prevalence was highest in rectal swabs (32.9%) and human stool samples (74.2%), with lower rates in fecal samples (25.9%), milk (25.7%), wall swabs (13.1%), and water (10%). All isolates showed 100% resistance to clindamycin, while being completely sensitive to imipenem and amikacin. Multidrug resistance was found in 90.1% of the isolates, and 16S rRNA was detected in 90% of randomly selected Campylobacter spp. The hipO, cadF, and ceuE genes were detected in 77.8%, 33.3%, and 22.2% of the isolates, respectively. Phylogenetic analysis of the 16S rRNA gene showed significant congruence either between the tested isolates and each other or with other isolates in the gene bank, confirming the zoonotic transmission of multi-drug-resistant Campylobacter spp. This highlights the urgent need for improved biosecurity on farms, better food handling practices, and heightened public health awareness to mitigate the risk of Campylobacteriosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.